To further clarify the mechanism underlying the functions of the four previously discovered key genes (CCR2, CCR4, P2RY12, and P2RY13) in the tumor microenvironment, we divided LUAD patients into high-expression groups and low-expression groups according to the four gene expression levels. The gene discussed is CCR2; the disease is neoplasm.